Akers bioscience plc share price
Yes. On November 22, 2013, ahead of our listing on the Nasdaq Capital Market, we had a reverse split (consolidation) at a ratio of 1 new common share for every 156 common shares held (1:156) . On November 8, 2018, we had a reverse split (consolidation) at a ratio of 1 new common share for every 8 common shares held (1:8). AKERS BIOSCIENCES INC Share Price - AKR Share Price Latest Akers Biosciences Inc Share Price - Live AKR share price quotes, charts, profile, RNS & company financials for LON:AKR NASDAQ:AKER Akers Biosciences Stock Price, Forecast & News Akers Biosciences, Inc., together with its subsidiaries, develops, manufactures, and supplies rapid screening and testing products designed to deliver healthcare information to healthcare providers and consumers in the United States, the People's Republic of China, and internationally. Akers Biosciences Inc. (AKER) Stock Price, Quote, History ...
Akers Biosciences, Inc. (AKER) Stock Analysis & News ...
Akers Biosciences Inc shares outstanding from 2012 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares. Akers Biosciences (AKER) Stock Price History | wallmine Akers Biosciences, Inc. develops health information technologies. It engages in the developing, manufacturing, and supplying screening and testing products to deliver healthcare information to consumers and healthcare providers. Its products include clinical diagnostics, safety diagnostics, wellness products, and tests in development. The company was founded by Raymond Francis Akers, … Akers Company Overview Biosciences, Inc. NasdaqCM: AKER ... We are valuing Akers using a P/S multiple of 5.0x. We apply this multiple to our FY15 estimated revenue per share projection of $2.77 and derive a target price of $13.85. Investment Highlights Over 125% revenue increase in 2013; anticipating sales growth and margin improvement going forward
Real-time trade and investing ideas on Akers Biosciences Inc. AKER from the largest community of traders and investors.
AKER Stock Price | Akers Biosciences Inc. Stock Quote (U.S ...
Akers Biosciences, Inc. engages in the development, manufacture, and supply of screening and testing products. Its products include clinical diagnostics and
Akers Biosciences (AKER) Stock Price History | wallmine Akers Biosciences, Inc. develops health information technologies. It engages in the developing, manufacturing, and supplying screening and testing products to deliver healthcare information to consumers and healthcare providers. Its products include clinical diagnostics, safety diagnostics, wellness products, and tests in development. The company was founded by Raymond Francis Akers, …
AKER | Complete Akers Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
AKER Stock Quote - Akers Biosciences Inc. Akers Biosciences Inc. - AKER (NASDAQ-CM) 3.11 . 0.07 Arix Bioscience plc : Imara Files for Proposed Initial Public Offering in the United States. PR Newswire (Mon, Feb 17) Feb 13) Cohen Veterans Bioscience Launches New Veterans Advisory Council (VAC) To Address Brain Health Priorities. PR Newswire (Thu, Feb 13)
Akers Biosciences Inc shares outstanding from 2012 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares. Akers Biosciences (AKER) Stock Price History | wallmine Akers Biosciences, Inc. develops health information technologies. It engages in the developing, manufacturing, and supplying screening and testing products to deliver healthcare information to consumers and healthcare providers. Its products include clinical diagnostics, safety diagnostics, wellness products, and tests in development. The company was founded by Raymond Francis Akers, … Akers Company Overview Biosciences, Inc. NasdaqCM: AKER ... We are valuing Akers using a P/S multiple of 5.0x. We apply this multiple to our FY15 estimated revenue per share projection of $2.77 and derive a target price of $13.85. Investment Highlights Over 125% revenue increase in 2013; anticipating sales growth and margin improvement going forward